Navigation Links
Simple, inexpensive and objective tools for the assessment of mucosal inflammation: fecal markers

UC and CD, the two major forms of IBD are chronic, idiopathic inflammatory conditions of the gut with a typically relapsing and remitting course. A prominent feature in mucosal biopsies from patients with active IBD is infiltration by neutrophil granulocytes. Moreover, the number of eosinophil granulocytes is also increased in IBD. Upon activation, neutrophils release Calprotectin and MPO, two major neutrophil proteins, while eosinophils release the protein, EPX. Previous studies have shown that fecal markers may be used to differentiate IBD from functional gastrointestinal disorders, but the usefulness of these markers in monitoring therapy of patients with active relapse of IBD needs further evaluation.

A research article to be published on September 28, 2008 in the World Journal of Gastroenterology addresses this question. A research team led by Associate professor M Carlson, Department of Medical Sciences, Uppsala University, evaluated patients with previously diagnosed UC or CD before starting treatment, and after 4 and 8 week of treatment. Treatment outcome, based on clinical activity and endoscopic findings in UC patients, and clinical activity in CD patients, was evaluated together with fecal levels of FC, and compared with fecal MPO and EPX. Fecal samples were analyzed for FC with ELISA, and MPO and EPX with RIA.

The authors have previously reported that elevated fecal levels of EPX and MPO may be useful in monitoring therapy in UC. The present study confirmed previous findings that patients with a relapse of IBD had elevated fecal markers. Interestingly, this study also demonstrated that normalized FC level may be used as a surrogate marker for successful treatment outcome in IBD patients. However, patients with persistently elevated FC levels need further evaluation. FC and MPO provided better assessment of treatment outcome than EPX in patients with UC, whereas EPX has the potential to identify treatment outcome, especially in patients with CD. These findings suggest that fecal markers can be used as surrogate markers for successful treatment outcome in IBD patients. Fecal markers are simple, inexpensive and objective tools for the assessment of mucosal inflammation.


Contact: Jian-Xia Cheng
World Journal of Gastroenterology

Related medicine news :

1. New OPAL Therapy presents simple, cost-effective method of treating HIV infection
2. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
3. Simple, personalized interventions improve colorectal cancer screening rates
4. If you think cancer genes are simple, you dont know JAK
5. Handbooks in Health Care Company Offers Full Line of Inexpensive Educational Pocket Books
6. Inexpensive Compound Could Treat Severe Diarrhea
7. Study Finds Nearly One-Third of All Inexpensive Earrings Examined Tested Positive for Nickel
8. Study: Before a CT scan or angiogram, many people should take inexpensive drug to protect kidneys
9. Inexpensive Online Pain Education Program for Physicians as Effective as Live Presentations by National Experts
10. Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
11. Sangamo BioSciences Provides Update on Companys Accomplishments in 2007 and 2008 Objectives
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... Altec Products, ... sponsorship of the Microsoft Dynamics AXUG, GPUG and NAVUG Summits to take place ... NAVUG Summit are independent user conferences designed and led by users to provide ...
(Date:10/13/2015)... ... October 13, 2015 , ... Element Blue ™, a ... new company, RightSensor™ LLC, an Internet of Things (IoT) hardware supplier that delivers ... fully-managed approach for customers requiring sensor hardware for critical data environments. , RightSensor™, ...
(Date:10/13/2015)... ... 13, 2015 , ... Relay (, a technology company that ... significant contract that will provide its award-winning private messaging solution to Independence Blue ... success of its Relay program, IBX Wire™, which now has over 550,000 members ...
(Date:10/13/2015)... ... October 13, 2015 , ... e-con Systems Inc., a leading embedded ... See3CAM_CU40, the industry’s first RGB-IR pixel format camera with a USB 3.0 interface ... e-con’s See3CAM family of UVC USB 3.0 cameras, is based on the 1/3-inch OV4682 ...
(Date:10/13/2015)... Tenn. (PRWEB) , ... October 13, 2015 , ... A ... and that’s why SmileCareClub , the leading remote invisible aligner system, has joined ... who would otherwise go without it. For each aligner treatment plan purchased, SmileCareClub will ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)...  EndoChoice Holdings, Inc. (NYSE:  GI) announced today that ... on Thursday, November 5, 2015 before the market open. ... . --> EndoChoice will hold ... 9:00 a.m. ET to discuss the results. The dial-in ... 317-5469 for international callers. A live webcast of the ...
(Date:10/13/2015)... Regen BioPharma, Inc. , ... Harry Lander , PhD as its new president.  Dr. Lander ... David Koos as Regen BioPharma prepares to take the ... --> Regen BioPharma, Inc. , (OTCBB: RGBP, ... , PhD as its new president.  Dr. Lander will work ...
(Date:10/13/2015)... 13, 2015 China Jo-Jo Drugstores, ... Jo-Jo "), a leading China-based retail, wholesale and online ... own online and retail pharmacies, announced preliminary half year ... online pharmacy through , growing 438% year ... 25%. China Jo-Jo,s online sales ...
Breaking Medicine Technology: